A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
Clinical Application of the Prototype J-PET Device
- Status
- COMPLETED
- Phase
- N/A
Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
- Status
- RECRUITING
- Phase
- N/A
68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- NA
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
"Receptor Radionuclide Therapy With 177Lu-DOTATOC
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- Status
- RECRUITING
- Phase
- PHASE1
An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- N/A
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
- Status
- RECRUITING
- Phase
- PHASE2
Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Status
- RECRUITING
- Phase
- PHASE3